Bioanalytical chromatographic methods for the determination of catechol-O-methyltransferase inhibitors in rodents and human samples: A review

Analytica Chimica Acta

Volumn 710, Issue , 2012, Pages 17-32

  Gonçalves, Daniela ^a,b   Alves, Gilberto ^b,c   Soares da Silva, Patrício ^d   Falcão, Amílcar ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^d DEPARTMENT OF RESEARCH AND DEVELOPMENT   (Portugal)

Author keywords

Bioanalytical chromatographic methods; Catechol O methyltransferase inhibitors; Entacapone; Nebicapone; Nitecapone; Tolcapone

Indexed keywords

CATECHOL-O-METHYLTRANSFERASE; CHROMATOGRAPHIC METHODS; ENTACAPONE; NEBICAPONE; NITECAPONE; TOLCAPONE;

CHEMICAL COMPOUNDS; CHROMATOGRAPHIC ANALYSIS; DRUG PRODUCTS; ELECTROCHEMICAL SENSORS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBIC CHROMATOGRAPHY; LIQUIDS; MAMMALS; MASS SPECTROMETRY; METABOLISM; METABOLITES; PHARMACOKINETICS; PHENOLS; SOLVENT EXTRACTION;

CHEMICAL DETECTION;

DRUG METABOLITE; ENTACAPONE; NEBICAPONE; NITECAPONE; TOLCAPONE;

ANALYTIC METHOD; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DETERMINATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG STABILITY; DRUG STRUCTURE; ELECTROCHEMICAL DETECTION; FIRST PASS EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; RODENT; SHORT SURVEY; SOLID PHASE EXTRACTION; ULTRAVIOLET RADIATION;

ANIMALS; ANTIPARKINSON AGENTS; CATECHOL O-METHYLTRANSFERASE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROCHEMICAL TECHNIQUES; ENZYME INHIBITORS; HUMANS; MASS SPECTROMETRY; PARKINSON DISEASE;

RODENTIA;

EID: 84155162415     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2011.10.026     Document Type: Short Survey

References (78)

1. Weintraub D., Comella C.L., Horn S.S. Am. J. Manag. Care 2008, 14:S40-S48.
2. Alves G., Forsaa E.B., Pedersen K.F., Gjerstad M.D., Larsen J.P. J. Neurol. 2008, 255:18-32.
3. Hauser R.A. Eur. Neurol. 2009, 62:1-8.
4. Linazasoro G. Parkinsonism Relat. Disord. 2009, 15:401-405.
5. Solla P., Cannas A., Marrosu F., Marrosu M.G. Neuropsychiatr. Dis. Treat. 2010, 6:483-490.
6. Abbruzzese G. Neurol. Sci. 2008, 29:S377-S379.
7. Kaakkola S. Drugs 2000, 59:1233-1250.
8. Khor S.P., Hsu A. Curr. Clin. Pharmacol. 2007, 2:234-243.
9. Bonifácio M.J., Palma P.N., Almeida L., Soares-da-Silva P. CNS Drug Rev. 2007, 13:352-379.
10. Tai C.H., Wu R.M. Acta Med. Okayama 2002, 56:1-6.
11. Männistö P.T., Kaakkola S. Pharmacol. Rev. 1999, 51:593-628.
12. Learmonth D.A., Kiss L.E., Soares-da-Silva P. Int. Rev. Neurobiol. 2010, 95:119-162.
13. Forsberg M., Lehtonen M., Heikkinen M., Savolainen J., Järvinen T., Männistö P.T. J. Pharmacol. Exp. Ther. 2003, 304:498-506.
14. Lees A.J. CNS Neurosci. Ther. 2008, 14:83-93.
15. Keating G.M., Lyseng-Williamson K.A. CNS Drugs 2005, 19:165-184.
16. Assal F., Spahr L., Hadengue A., Rubbia-Brandt L., Burkhard P.R. Lancet 1998, 352:958.
17. Colosimo C. J. Neurol. 1999, 246:880-882.
18. Almeida L., Soares-da-Silva P. Drugs R D 2003, 4:207-217.
19. Ferreira J.J., Rascol O., Poewe W., Sampaio C., Rocha J.F., Nunes T., Almeida L., Soares-da-Silva P. CNS Neurosci. Ther. 2010, 16:337-347. (Abstract).
20. Kiss L.E., Ferreira H.S., Torrão L., Bonifácio M.J., Palma P.N., Soares-da-Silva P., Learmonth D.A. J. Med. Chem. 2010, 53:3396-3411.
21. Kambur O., Männistö P.T., Pusa A.M., Käenmäki M., Kalso E.A., Kontinen V.K. Eur. J. Pain 2011, 10.1016/j.ejpain.2010.12.001.
22. Schultz E., Tarpila S., Bäckström A.C., Gordin A., Nissinen E., Pohto P. Eur. J. Clin. Pharmacol. 1991, 40:577-580.
23. Keränen T., Gordin A., Karlsson M., Korpela K., Pentikäinen P.J., Rita H., Schultz E., Seppälä L., Wikberg T. Eur. J. Clin. Pharmacol. 1994, 46:151-157.
24. Jorga K.M., Fotteler B., Heizmann P., Zürcher G. Eur. J. Clin. Pharmacol. 1998, 54:443-447.
25. Wright L.C., Maia J., Loureiro A.I., Almeida L., Soares-Da-Silva P. Drug Metab. Lett. 2010, 4:149-162.
26. Jorga K.M., Kroodsma J.M., Fotteler B., Heizmann P., Meyer J., Rasch M.C., van Hattum J. Clin. Pharmacol. Ther. 1998, 63:646-654.
27. Dingemanse J., Jorga K.M., Schmitt M., Gieschke R., Fotteler B., Zürcher G., Da Prada M., van Brummelen P. Clin. Pharmacol. Ther. 1995, 57:508-517.
28. Bonifácio M.J., Loureiro A.I., Torrão L., Fernandes-Lopes C., Wright L., Pinho M.J., Soares-da-Silva P. Biochem. Pharmacol. 2009, 78:1043-1051.
29. Jorga K., Fotteler B., Heizmann P., Gasser R. Br. J. Clin. Pharmacol. 1999, 48:513-520.
30. Sun J., Von Tungeln L.S., Hines W., Beger R.D. J. Chromatogr. B 2009, 877:2557-2565.
31. Wikberg T., Vuorela A., Ottoila P., Taskinen J. Drug Metab. Dispos. 1993, 21:81-92.
32. Taskinen J., Wikberg T., Ottoila P., Kanner L., Lotta T., Pippuri A., Bäckström R. Drug Metab. Dispos. 1991, 19:178-183.
33. Wikberg T., Taskinen J. Drug Metab. Dispos. 1993, 21:325-333.
34. Loureiro A.I., Bonifácio M.J., Fernandes-Lopes C., Almeida L., Wright L.C., Soares-Da-Silva P. Drug Metab. Dispos. 2006, 34:1856-1862.
35. Heizmann P., Schmitt M., Leube J., Martin H., Saner A. J. Chromatogr. B 1999, 730:153-160.
36. Smith K.S., Smith P.L., Heady T.N., Trugman J.M., Harman W.D., Macdonald T.L. Chem. Res. Toxicol. 2003, 16:123-128.
37. Forsberg M.M., Huotari M., Savolainen J., Männistö P.T. Eur. J. Pharm. Sci. 2005, 24:503-511.
38. Savolainen J., Leppanen J., Forsberg M., Taipale H., Nevalainen T., Huuskonen J., Gynther J., Mannisto P.T., Jarvinen T. Life Sci. 2000, 67:205-216.
39. Novaroli L., Doulakas G.B., Reist M., Rolando B., Fruttero R., Gasco A., Carrupt P. Helv. Chim. Acta 2006, 89:144-152.
40. PubChem Compound Database National Center for Biotechnology Information (NCBI) 2011, (accessed 05.05.11). http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi%3Fcid=9838389%26loc=ec_rcs.
41. Timm U., Erdin R. J. Chromatogr. 1992, 593:63-68.
42. Yadav M., Dixit P., Trivedi V., Gandhi A., Senger A., Guttikar S., Singhal P., Shrivastav P.S. J. Chromatogr. B 2009, 877:533-540.
43. Bugamelli F., Marcheselli C., Barba E., Raggi M.A. J. Pharm. Biomed. Anal. 2010, 54:562-567.
44. Ramakrishna N.V., Vishwottam K.N., Wishu S., Koteshwara M., Chidambara J. J. Chromatogr. B 2005, 823:189-194.
45. Wikberg T., Taskinen J. J. Pharm. Biomed. Anal. 1991, 9:59-64.
46. Karlsson M., Wikberg T. J. Pharm. Biomed. Anal. 1992, 10:593-600.
47. Lehtonen P., Lehtinen S., Mälkki-Laine L., Wikberg T. J. Chromatogr. A 1999, 836:173-188.
48. Keski-Hynnilä H., Raanaa K., Forsberg M., Männistö P., Taskinen J., Kostiainen R. J. Chromatogr. B 2001, 759:227-236.
49. Guidance for Industry: Bioanalytical Method Validation 2001, Food and Drugs Administration, Rockville, MD, USA, (accessed 12.09.11). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf.
50. Guideline on Validation of Bioanalytical Methods 2009, European Medicine Agency, London, UK, (accessed 12.09.11). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/12/WC500018062.pdf.
51. Nowatzke W., Woolf E. AAPS J. 2007, 9:E117-E122.
52. Nováková L., Vlcková H. Anal. Chim. Acta 2009, 656:8-35.
53. Sundberg S., Scheinin M., Ojala-Karlsson P., Kaakkola S., Akkila J., Gordin A. Clin. Pharmacol. Ther. 1990, 48:356-364.
54. Rouru J., Gordin A., Huupponen R., Huhtala S., Savontaus E., Korpela K., Reinikainen K., Scheinin M. Eur. J. Clin. Pharmacol. 1999, 55:461-467.
55. Heikkinen H., Saraheimo M., Antila S., Ottoila P., Pentikäinen P.J. Eur. J. Clin. Pharmacol. 2001, 56:821-826.
56. Kuoppamäki M., Korpela K., Marttila R., Kaasinen V., Hartikainen P., Lyytinen J., Kaakkola S., Hänninen J., Löyttyniemi E., Kailajärvi M., Ruokoniemi P., Ellmén J. Eur. J. Clin. Pharmacol. 2009, 65:443-455.
57. Solakyildirim K., Zhang Z., Linhardt R.J. Anal. Biochem. 2010, 397:24-28.
58. Swartz M.E. Separation Science Redefined 2005, pp. 8-14. http://chromatographyonline.findanalytichem.com/lcgc/data/articlestandard//lcgc/242005/164646/article.pdf (accessed 20.09.11).
59. Eugster P.J., Guillarme D., Rudaz S., Veuthey J.L., Carrupt P.A., Wolfender J.L. J. AOAC Int. 2011, 94:51-70.
60. Guillarme D., Ruta J., Rudaz S., Veuthey J.L. Anal. Bioanal. Chem. 2010, 397:1069-1082.
61. Wang X., Sun H., Zhang A., Wang P., Han Y. J. Sep. Sci. 2011, (Abstract). 10.1002/jssc.201100333.
62. Lautala P., Kivimaa M., Salomies H., Elovaara E., Taskinen J. Pharm. Res. 1997, 14:1444-1448.
63. Lautala P., Ethell B.T., Taskinen J., Burchell B. Drug Metab. Dispos. 2000, 28:1385-1389.
64. Elovaara E., Mikkola J., Luukkanen L., Antonio L., Fournel-Gigleux S., Burchell B., Magdalou J., Taskinen J. Drug Metab. Dispos. 2004, 32:1426-1433.
65. Hakala K.S., Suchanova B., Luukkanen L., Ketola R.A., Finel M., Kostiainen R. Anal. Biochem. 2005, 341:105-112.
66. Staack R.F., Varesio E., Hopfgartner G. Rapid Commun. Mass Spectrom. 2005, 19:618-626.
67. Paim C.S., Gonçalves H.M.L., Miron D., Sippel J., Steppe M. Chromatographia 2007, 65:595-599.
68. Paim C.S., Martins M.T., Malesuik M.D., Steppe M. J. Chromatogr. Sci. 2010, 48:755-759.
69. Sivasubramanian L., Lakshmi K.S., Pathuri R.R. J. Pharm. Res. 2009, 2:1850-1851.
70. Doshi A.S., Upadhyay K.J., Mehta T.N., Nanda N. J. AOAC Int. 2009, 92:394-403.
71. Soukhova N., Kassymbek Z., Bradby S., Martin-Esker A., White P., Wahab S. J. Pharm. Biomed. Anal. 2011, 54:860-865.
72. Ottoila P., Pakkala E., Karlsson C., Taskinen J. Biol. Mass Spectrom. 1991, 20:771-776. (Abstract).
73. Antonio L., Grillasca J.P., Taskinen J., Elovaara E., Burchell B., Piet M.H., Ethell B., Ouzzine M., Fournel-Gigleux S., Magdalou J. Drug Metab. Dispos. 2002, 30:199-207.
74. Angerer J., Schaller K. Analyses of Hazardous Substances in Biological Materials 2001, vol. 7. Wiley-VCH, Weinheim.
75. Jandera P., Skeifíková V., Rehová L., Hájek T., Baldriánová L., Skopová G., Kellner V., Horna A. J. Sep. Sci. 2005, 28:1005-1022.
76. Keski-Hynnilä H., Luukkanen L., Taskinen J., Kostiainen R. J. Am. Soc. Mass Spectrom. 1999, 10:537-545.
77. Maeda K., Sugiyama Y. Adv. Drug Deliv. Rev. 2011, 63:532-538.
78. Guideline on the Investigation of Bioequivalence 2010, European Medicine Agency, London, UK, (accessed 20.09.11). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500070039.pdf.